BRADVITE-M

This brand name is authorized in Nigeria.

Active ingredients

The drug BRADVITE-M contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 81G40H8B0T - VITAMIN A
 

Vitamin A plays an important role in the visual process. It is isomerised to the 11-cis isomer and subsequently bound to the opsin to form the photoreceptor for vision under subdued light. Vitamin A also participates in the formation and maintenance of the integrity of epithelial tissues and mucous membranes.

 
Read more about Vitamin A
2
UNII X66NSO3N35 - THIAMINE
 

Thiamine pyrophosphate (TPP), the coenzymatic form of thiamine, is involved in two main types of metabolic reactions: decarboxylation of α-ketoacids (e.g. pyruvate, α-ketoglutarate and branched-chain keto acids) and transketolation (e.g. among hexose and pentose phosphates). Therefore, the principal physiological role of thiamine is as a coenzyme in carbohydrate metabolism, where TPP is required for several stages in the breakdown of glucose to provide energy.

 
Read more about Vitamin B1
3
UNII TLM2976OFR - RIBOFLAVIN
 

Riboflavine is phosphorylated to flavine mononucleotide and flavine adenine dinucleotide which act as co-enzymes in the respiratory chain and in oxidative phosphorylation. Riboflavine deficiency presents with ocular symptoms, as well as lesions on the lips and at angles of the mouth.

 
Read more about Riboflavin
4
UNII P6YC3EG204 - CYANOCOBALAMIN
 

Hydroxocobalamin is used in the treatment and prevention of Vitamin B12 deficiency. For adults, the daily requirement of Vitamin B12 is probably about 1 to 2 micrograms and this amount is present in most normal diets. However, Vitamin B12 only occurs in animal products, not in vegetables, and therefore strict vegetarian or vegan diets that exclude dairy products may provide an inadequate amount, although a deficiency may not be apparent for many years.

 
Read more about Vitamin B12
5
UNII PQ6CK8PD0R - ASCORBIC ACID
 

Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs.

 
Read more about Vitamin C
6
Vitamin D
UNII 9VU1KI44GP - VITAMIN D
7
UNII 25X51I8RD4 - NIACINAMIDE
 
Read more about Niacinamide

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A11-100610 Drops Bradvite-M drop SOL_DROPS 2000iu; 1mg; 0.5mg; 500mcg; 40mg; 200iu; 2.5mg 15ML 89 NF-PP-262250 Bradvite-M drop Multivitamin drop each 0.6ml contain Vit A 2000I.U, Vit B1 1mg, Vit B2 0.5mg, Vit B6 500mcg, Vit C 40mg, Vit D 200I.U, Nicotinamide 2.5mg A11-100610 Drugs Nigerian Products 15ml OTC 6/15/2022 BIOMEDICAL LIMITED, 1 OHIMEGE ROAD INDUSTRIAL ESTATE ILORIN 9027475550 biomedicalng@yahoo.co.uk BIOMEDICAL LIMITED, 1, OHIMEGE ROAD, INDUSTRIAL ESTATE, ILORIN, KWARA STATE , Nigeria 21/12/2023
A11-1311 Drops Bradvite - M Multivitamin Drops SOL_DROPS 2000iu; 1mg; 0.5mg; 500mcg; 40mg; 200iu; 2.5mg X 15MLS Bradvite - M Multivitamin Drops A11-1311 Bradvite - M VITAMIN A, VITAMIN B1, VITAMIN B2, VITAMIN B6, VITAMIN C, VITAMIN D, NICOTINAMIDE MULTIVITAMIN VITAMIN A 2000 I.U, VITAMIN B1 1MG, VITAMIN B2 0.5MG, VITAMIN B6 500MCG, VITAMIN C 40MG, VITAMIN D 200 I.U, NICOTINAMIDE 2.5MG DROPS X 15MLS OVER THE COUNTER TREATMENT OF VITAMIN DEFICIENCY BIOMEDICAL LIMITED NIGERIA BIOMEDICAL LIMITED NIGERIA 09/29/2022 09/28/2027 29/09/2022

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A11BA Multivitamins, plain A Alimentary tract and metabolism → A11 Vitamins → A11B Multivitamins, plain
Discover more medicines within A11BA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A11-100610, A11-1311

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.